Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in Br J Radiol

Retrieve available abstracts of 94 articles:
HTML format

Single Articles

    June 2021
  1. KUMASAKA S, Motegi S, Kumasaka Y, Nishikata T, et al
    Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.
    Br J Radiol. 2021 Jun 11:20210459. doi: 10.1259/bjr.20210459.
    PubMed     Abstract available

  2. QUINTERO P, Cheng Y, Benoit D, Moore C, et al
    Effect of treatment planning system parameters on beam modulation complexity for treatment plans with single-layer multi-leaf collimator and dual-layer stacked multi-leaf collimator.
    Br J Radiol. 2021;94:20201011.
    PubMed     Abstract available

    April 2021
  3. URASE Y, Ueno Y, Tamada T, Sofue K, et al
    Comparison of prostate imaging reporting and data system v2.1 and 2 in transition and peripheral zones: evaluation of interreader agreement and diagnostic performance in detecting clinically significant prostate cancer.
    Br J Radiol. 2021 Apr 21:20201434. doi: 10.1259/bjr.20201434.
    PubMed     Abstract available

  4. KUO YH, Liang JA, Chen GH, Li CC, et al
    Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis.
    Br J Radiol. 2021 Apr 16:20200456. doi: 10.1259/bjr.20200456.
    PubMed     Abstract available

  5. BEDFORD JL, Hanson IM
    Optimisation of a composite difference metric for prompt error detection in real-time portal dosimetry of simulated volumetric modulated arc therapy.
    Br J Radiol. 2021;94:20201014.
    PubMed     Abstract available

  6. YANG FJ, Ai SY, Wu R, Lv Y, et al
    Impact of total variation regularized expectation maximization reconstruction on the image quality of (68)Ga-PSMA PET: a phantom and patient study.
    Br J Radiol. 2021;94:20201356.
    PubMed     Abstract available

    March 2021
  7. HE X, Xiong H, Zhang H, Liu X, et al
    Value of MRI texture analysis for predicting new Gleason grade group.
    Br J Radiol. 2021 Mar 11:20210005. doi: 10.1259/bjr.20210005.
    PubMed     Abstract available

  8. HWANG ME, Mayeda M, Shaish H, Elliston CD, et al
    Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
    Br J Radiol. 2021;94:20200433.
    PubMed     Abstract available

    February 2021
  9. KOWA JY, Soneji N, Sohaib SA, Mayer E, et al
    Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.
    Br J Radiol. 2021 Feb 15:20201423. doi: 10.1259/bjr.20201423.
    PubMed     Abstract available

    January 2021
  10. HEARN N, Blazak J, Vivian P, Vignarajah D, et al
    Prostate cancer GTV delineation with biparametric MRI and (68)Ga-PSMA-PET: comparison of expert contours and semi-automated methods.
    Br J Radiol. 2021 Jan 28:20201174. doi: 10.1259/bjr.20201174.
    PubMed     Abstract available

    October 2020
  11. UGURLUER G, Atalar B, Zoto Mustafayev T, Gungor G, et al
    Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results.
    Br J Radiol. 2020 Oct 23:20200696. doi: 10.1259/bjr.20200696.
    PubMed     Abstract available

  12. ALONGI F, Rigo M, Figlia V, Cuccia F, et al
    Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
    Br J Radiol. 2020 Oct 23:20200848. doi: 10.1259/bjr.20200848.
    PubMed     Abstract available

  13. WADERA A, Alabousi M, Pozdnyakov A, Kashif Al-Ghita M, et al
    Impact of PI-RADS 3 lesions on the diagnostic accuracy of MRI for detecting prostate cancer and the prevalence of prostate cancer within each PI-RADS category: A systematic review and Meta-Analysis.
    Br J Radiol. 2020 Oct 1:20191050. doi: 10.1259/bjr.20191050.
    PubMed     Abstract available

  14. CHETIYAWARDANA G, Hoskin PJ, Tsang YM
    The implementation of an empty bladder filling protocol for localised prostate volumetric modulated arctherapy (VMAT): early results of a single institution service evaluation.
    Br J Radiol. 2020;93:20200548.
    PubMed     Abstract available

  15. GIGANTI F, Allen C
    Imaging quality and prostate MR: it's time to improve.
    Br J Radiol. 2020 Oct 1:20200934. doi: 10.1259/bjr.20200934.
    PubMed     Abstract available

    September 2020
  16. GIGANTI F, Stavrinides V, Stabile A, Osinibi E, et al
    Prostate cancer measurements on serial MRI during active surveillance: it's time to be PRECISE.
    Br J Radiol. 2020 Sep 21:20200819. doi: 10.1259/bjr.20200819.
    PubMed     Abstract available

  17. ALSHEHRI AHD, Osman SOS, Prise KM, Campfield C, et al
    A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer.
    Br J Radiol. 2020 Sep 3:20200775. doi: 10.1259/bjr.20200775.
    PubMed     Abstract available

    August 2020
  18. PILIERO MA, Casiraghi M, Bosetti DG, Cima S, et al
    Patient-based low dose cone beam CT acquisition settings for prostate image-guided radiotherapy treatments on a Varian TrueBeam linear accelerator.
    Br J Radiol. 2020 Aug 27:20200412. doi: 10.1259/bjr.20200412.
    PubMed     Abstract available

  19. KAO J, Karwowski P, Pettit J, Barney AK, et al
    Multiparametric prostate MRI-based intensity-modulated radiation therapy guided by prostatic calcifications.
    Br J Radiol. 2020 Aug 26:20200571. doi: 10.1259/bjr.20200571.
    PubMed     Abstract available

  20. YAN M, Moideen N, Bratti VF, Moraes FY, et al
    Stereotactic body radiotherapy (SBRT) in metachronousoligometastatic prostate cancer: a systematic review and meta-analysis on the current prospective evidence.
    Br J Radiol. 2020 Aug 21:20200496. doi: 10.1259/bjr.20200496.
    PubMed     Abstract available

  21. SCHUMACHER LD, Dal Pra A, Hoffe SE, Mellon EA, et al
    Toxicity reduction required for MRI-guided radiotherapy to be cost-effective in the treatment of localized prostate cancer.
    Br J Radiol. 2020 Aug 12:20200028. doi: 10.1259/bjr.20200028.
    PubMed     Abstract available

  22. YOUNG S, Gasparetto A, Jalaeian H, Golzarian J, et al
    Biomarkers in the setting of benign prostatic hyperplasia-induced lower urinary tract symptoms: what an interventional radiologist needs to know.
    Br J Radiol. 2020 Aug 6:20200484. doi: 10.1259/bjr.20200484.
    PubMed     Abstract available

  23. SINGH G, Kamal R, Thaper D, Oinam AS, et al
    Voxel based evaluation of sequential radiotherapy treatment plans with different dose fractionation schemes.
    Br J Radiol. 2020;93:20200197.
    PubMed     Abstract available

    July 2020
  24. TAYLOR T, Richmond N
    A UK wide study of current prostate planning practice.
    Br J Radiol. 2020;93:20200142.
    PubMed     Abstract available

    June 2020
  25. ASHTON J, Bristow R
    Bad neighbours: hypoxia and genomic instability in prostate cancer.
    Br J Radiol. 2020 Jun 18:20200087. doi: 10.1259/bjr.20200087.
    PubMed     Abstract available

  26. ZAWAIDEH JP, Sala E, Pantelidou M, Shaida N, et al
    Comparison of likert and PI-RADS version 2 MRI scoring systems for the detection of clinically significant prostate cancer.
    Br J Radiol. 2020 Jun 1:20200298. doi: 10.1259/bjr.20200298.
    PubMed     Abstract available

    April 2020
  27. DEVLIN L, Dodds D, Sadozye A, McLoone P, et al
    Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
    Br J Radiol. 2020;93:20190789.
    PubMed     Abstract available

    March 2020
  28. EMARA DM, Naguib NN, Yehia M, El Shafei MM, et al
    Ultrasound elastography in characterization of prostatic lesions: correlation with histopathological findings.
    Br J Radiol. 2020 Mar 6:20200035. doi: 10.1259/bjr.20200035.
    PubMed     Abstract available

    February 2020
  29. ADRIAN G, Konradsson E, Lempart M, Back S, et al
    The FLASH effect depends on oxygen concentration.
    Br J Radiol. 2020;93:20190702.
    PubMed     Abstract available

    January 2020
  30. DEANTONI CL, Fodor A, Cozzarini C, Fiorino C, et al
    Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases.
    Br J Radiol. 2020 Jan 23:20190353. doi: 10.1259/bjr.20190353.
    PubMed     Abstract available

  31. SUSHENTSEV N, Caglic I, Sala E, Shaida N, et al
    The effect of capped biparametric magnetic resonance imaging slots on weekly prostate cancer imaging workload.
    Br J Radiol. 2020 Jan 23:20190929. doi: 10.1259/bjr.20190929.
    PubMed     Abstract available

  32. KEENAN L, Ibrahim N, Dunne MT, Finn M, et al
    The effect of anaemia on normal tissue toxicity and survival outcomes in prostate cancer treated with radical radiotherapy and neo-adjuvant androgen deprivation.
    Br J Radiol. 2020 Jan 16:20190577. doi: 10.1259/bjr.20190577.
    PubMed     Abstract available

  33. KIM E, Kim CK, Kim HS, Jang DP, et al
    Histogram analysis from stretched exponential model on diffusion-weighted imaging: evaluation of clinically significant prostate cancer.
    Br J Radiol. 2020 Jan 9:20190757. doi: 10.1259/bjr.20190757.
    PubMed     Abstract available

  34. WANG T, Zhou J, Tian S, Wang Y, et al
    A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy.
    Br J Radiol. 2020 Jan 6:20190845. doi: 10.1259/bjr.20190845.
    PubMed     Abstract available

    December 2019
  35. TSANG YM, Vignarajah D, Mcwilliam A, Tharmalingam H, et al
    A pilot study on dosimetric and radiomics analysis of urethral strictures following HDR brachytherapy as monotherapy for localized prostate cancer.
    Br J Radiol. 2019 Dec 2:20190760. doi: 10.1259/bjr.20190760.
    PubMed     Abstract available

    November 2019
  36. BHATTACHARYYA T, Koto M, Ikawa H, Hayashi K, et al
    First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry.
    Br J Radiol. 2019;92:20190370.
    PubMed     Abstract available

    October 2019
  37. SUMAN S, Parghane RV, Joshi A, Prabhash K, et al
    Therapeutic efficacy, Prognostic variables and Clinical Outcome of (177)Lu-PSMA-617 PRLT in Progressive mCRPC following multiple lines of treatment: prognostic implications of high FDG uptake on dual tracer PET-CT vis-a-vis Gleason Score in such cohor
    Br J Radiol. 2019 Oct 10:20190380. doi: 10.1259/bjr.20190380.
    PubMed     Abstract available

  38. ZHANG F, Liu CL, Chen Q, Shao SC, et al
    Accuracy of multiparametric magnetic resonance imaging for detecting extracapsular extension in prostate cancer: a systematic review and meta-analysis.
    Br J Radiol. 2019 Oct 9:20190480. doi: 10.1259/bjr.20190480.
    PubMed     Abstract available

  39. MAHDAVI SR, Tavakol A, Sanei M, Molana SH, et al
    Use of artificial neural network for pretreatment verification of intensity modulation radiation therapy fields.
    Br J Radiol. 2019;92:20190355.
    PubMed     Abstract available

    September 2019
  40. SCHICK U, Lucia F, Dissaux G, Visvikis D, et al
    MRI derived radiomics: Methodology and clinical applications in the field of pelvic oncology.
    Br J Radiol. 2019 Sep 20:20190105. doi: 10.1259/bjr.20190105.
    PubMed     Abstract available

    July 2019
  41. SUN Y, Williams S, Byrne D, Keam S, et al
    Association analysis between quantitative MRI features and hypoxia-related genetic profiles in prostate cancer: a pilot study.
    Br J Radiol. 2019 Jul 30:20190373. doi: 10.1259/bjr.20190373.
    PubMed     Abstract available

  42. KIM SJ, Lee SW
    Diagnostic accuracy of (F)18 flucholine PET/CT for preoperative lymph node staging in newly diagnosed prostate cancer patients; a systematic review and meta-analysis.
    Br J Radiol. 2019 Jul 5:20190193. doi: 10.1259/bjr.20190193.
    PubMed     Abstract available

  43. KISHAN AU, Tyran M, Weng J, Upadhyaya S, et al
    Stereotactic body radiotherapy to the prostate and pelvic lymph nodes: A detailed dosimetric analysis of a phase II prospective trial.
    Br J Radiol. 2019;92:20181001.
    PubMed     Abstract available

    June 2019
  44. ACAR E, Leblebici A, Ellidokuz BE, Basbinar Y, et al
    Machine learning for differentiating metastatic and completely responded sclerotic bone lesion in prostate cancer: A retrospective radiomics study.
    Br J Radiol. 2019 Jun 20:20190286. doi: 10.1259/bjr.20190286.
    PubMed     Abstract available

  45. SUREKA B, Elhence P, Khera PS, Choudhary GR, et al
    Quantitative contrast-enhanced perfusion kinetics in multiparametric MRI in differentiating prostate cancer from chronic prostatitis: results from a pilot study.
    Br J Radiol. 2019 Jun 11:20190181. doi: 10.1259/bjr.20190181.
    PubMed     Abstract available

  46. DE LEON J, Jameson MG, Rivest-Henault D, Keats S, et al
    Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy.
    Br J Radiol. 2019;92:20190056.
    PubMed     Abstract available

    April 2019
  47. TAMPONI M, Gabriele D, Maggio A, Stasi M, et al
    Prostate cancer dose-response, fractionation sensitivity and repopulation parameters evaluation from 25 international radiotherapy outcome data sets.
    Br J Radiol. 2019 Apr 24:20180823. doi: 10.1259/bjr.20180823.
    PubMed     Abstract available

  48. LEE SM, Wolfe K, Acher P, Liyanage SH, et al
    Multiparametric MRI appearances of primary granulomatous prostatitis.
    Br J Radiol. 2019 Apr 9:20180075. doi: 10.1259/bjr.20180075.
    PubMed     Abstract available

    March 2019
  49. WANG T, Press RH, Giles M, Jani AB, et al
    Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy.
    Br J Radiol. 2019 Mar 26:20190089. doi: 10.1259/bjr.20190089.
    PubMed     Abstract available

  50. KING AJ, Dudderidge T, Darekar A, Schimitz K, et al
    Establishing magnetic resonance imaging guided prostate intervention at a UK Centre.
    Br J Radiol. 2019 Mar 26:20180918. doi: 10.1259/bjr.20180918.
    PubMed     Abstract available

  51. JI Y, Litao R, Ren W, Dun G, et al
    Stiffness of prostate gland measured by transrectal Real-Time shear wave elastography for detection of prostate cancer: A feasibility study.
    Br J Radiol. 2019 Mar 15:20180970. doi: 10.1259/bjr.20180970.
    PubMed     Abstract available

  52. FRANZESE C, D'agostino G, Di Brina L, Navarria P, et al
    Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity.
    Br J Radiol. 2019 Mar 13:20190021. doi: 10.1259/bjr.20190021.
    PubMed     Abstract available

  53. PIERRE DE M, Roberto Luigi C, Julien G, Thibault T, et al
    Percutaneous MR-guided whole-gland prostate cancer cryoablation: safety considerations and oncologic results in 30 consecutive patients.
    Br J Radiol. 2019 Mar 8. doi: 10.1259/bjr.20180965.
    PubMed     Abstract available

    February 2019
  54. WANG H, Cooper BT, Schiff P, Sanfilippo NJ, et al
    Dosimetric assessment of tumor control probability in intensity and volumetric modulated radiotherapy plans.
    Br J Radiol. 2019;92:20180471.
    PubMed     Abstract available

    January 2019
  55. PATHMANATHAN AU, McNair HA, Schmidt MA, Brand DH, et al
    Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy.
    Br J Radiol. 2019 Jan 24:20180948. doi: 10.1259/bjr.20180948.
    PubMed     Abstract available

  56. COHEN J, Anvari A, Samanta S, Poirier Y, et al
    Mild hyperthermia as a localized radiosensitizer for deep-seated tumors: Investigation in an orthotopic prostate cancer model in mice.
    Br J Radiol. 2019 Jan 23:20180759. doi: 10.1259/bjr.20180759.
    PubMed     Abstract available

    December 2018
  57. NANDURKAR R, van Leeuwen P, Stricker P, Woo H, et al
    (68)Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.
    Br J Radiol. 2018 Dec 19:20180667. doi: 10.1259/bjr.20180667.
    PubMed     Abstract available

    November 2018
  58. GIACOMETTI V, King RB, Agnew CE, Irvine DM, et al
    An Evaluation of Techniques for Dose Calculation on Cone Beam Computed Tomography.
    Br J Radiol. 2018 Nov 15:20180383. doi: 10.1259/bjr.20180383.
    PubMed     Abstract available

  59. TAU N, Berlin A, Yeung I, Halankar J, et al
    Quantitative assessment of dynamic (18)F-Fluoromethycholine PET and Dynamic Contrast Enhanced MRI in High Risk Prostate Cancer.
    Br J Radiol. 2018 Nov 1:20180568. doi: 10.1259/bjr.20180568.
    PubMed     Abstract available

    Recent advances in theranostics and challenges for the future.
    Br J Radiol. 2018;91:20170893.
    PubMed     Abstract available

    October 2018
  61. JERECZEK-FOSSA BA, Rojas DP, Zerini D, Fodor C, et al
    Re-irradiation for isolated local recurrence of prostate cancer: MONO-INSTITUTIONAL series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
    Br J Radiol. 2018 Oct 31:20180494. doi: 10.1259/bjr.20180494.
    PubMed     Abstract available

    September 2018
  62. HEDGIRE S, Kilcoyne A, Tonyushkin A, Mao Y, et al
    Effect of androgen deprivation and radiation therapy on MRI fiber tractography in prostate cancer: Can we assess treatment response on imaging?
    Br J Radiol. 2018 Sep 13:20170170. doi: 10.1259/bjr.20170170.
    PubMed     Abstract available

    July 2018
  63. AZADI J, Nguyen ML, Leroy A, Macura KJ, et al
    The emerging role of imaging in prostate cancer secondary screening: multiparametric magnetic resonance imaging and the incipient incorporation of molecular imaging.
    Br J Radiol. 2018 Jul 26:20170960. doi: 10.1259/bjr.20170960.
    PubMed     Abstract available

    June 2018
  64. MULLANEY L, O'Shea E, Dunne MT, Thirion PG, et al
    A comparison of bladder volumes based on treatment planning Computed Tomography and BladderScan(R) BVI 6100 ultrasound device in a prostate radiation therapy population.
    Br J Radiol. 2018 Jun 11:20180160. doi: 10.1259/bjr.20180160.
    PubMed     Abstract available

  65. NGUYEN TB, Ushinsky A, Yang A, Nguyentat M, et al
    Utility of quantitative apparent diffusion coefficient measurements and normalized apparent diffusion coefficient ratios in the diagnosis of clinically significant peripheral zone prostate cancer.
    Br J Radiol. 2018 Jun 5:20180091. doi: 10.1259/bjr.20180091.
    PubMed     Abstract available

  66. MARTIN JM, Supiot S, Keall PJ, Catton CN, et al
    Moderately hypofractionated prostate external-beam radiotherapy: an emerging standard.
    Br J Radiol. 2018;91:20170807.
    PubMed     Abstract available

    May 2018
  67. KULKARNI HR, Singh A, Langbein T, Schuchardt C, et al
    Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.
    Br J Radiol. 2018 May 15:20180308. doi: 10.1259/bjr.20180308.
    PubMed     Abstract available

  68. TIMON G, Ciardo D, Bazani A, Marvaso G, et al
    Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of phase II trial AIRC-IG-13218.
    Br J Radiol. 2018 May 11:20160725. doi: 10.1259/bjr.20160725.
    PubMed     Abstract available

    April 2018
  69. JADVAR H, Colletti PM
    (18)F-NaF/(223)RaCl2 theranostics in metastatic prostate cancer: treatment response assessment and prediction of outcome.
    Br J Radiol. 2018 Apr 9:20170948. doi: 10.1259/bjr.20170948.
    PubMed     Abstract available

    March 2018
  70. JUNG SI, Jeon HJ, Park HS, Yu MH, et al
    Multiparametric MR imaging of peripheral zone prostate cancer: effect of postbiopsy hemorrhage on cancer detection according to Gleason score and tumour volume.
    Br J Radiol. 2018 Mar 9:20180001. doi: 10.1259/bjr.20180001.
    PubMed     Abstract available

    February 2018
  71. GODDARD L, Brodin NP, Bodner WR, Garg M, et al
    Comparing photon and proton based hypofractioned sbrt for prostate cancer accounting for robustness and realistic treatment deliverability.
    Br J Radiol. 2018 Feb 13:20180010. doi: 10.1259/bjr.20180010.
    PubMed     Abstract available

  72. KING RB, Osman SO, Fairmichael C, Irvine DM, et al
    Efficacy of a rectal spacer with prostate SABR-first UK experience.
    Br J Radiol. 2018;91:20170672.
    PubMed     Abstract available

  73. DI PAOLA V, Cybulski A, Belluardo S, Cavicchioli F, et al
    Evaluation of periprostatic neurovascular fibers before and after radical prostatectomy by means of 1.5 t mri diffusion tensor imaging.
    Br J Radiol. 2018 Feb 1:20170318. doi: 10.1259/bjr.20170318.
    PubMed     Abstract available

    January 2018

  74. Addendum to Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer. Br J Radiol 2005; 78: S103-S111.
    Br J Radiol. 2018 Jan 31:bjr11253478a. doi: 10.1259/bjr.11253478.

  75. DUFFTON A, Sadozye A, Devlin L, MacLeod N, et al
    Safety and feasibility of prostate stereotactic ablative radiotherapy using multi-modality imaging and flattening filter free.
    Br J Radiol. 2018 Jan 17:20170625. doi: 10.1259/bjr.20170625.
    PubMed     Abstract available

  76. ELFATAIRY KK, Filson CP, Sanda MG, Osunkoya AO, et al
    In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? a pilot test-retest reliability study.
    Br J Radiol. 2018 Jan 8:20170603. doi: 10.1259/bjr.20170603.
    PubMed     Abstract available

  77. TEOH EJ, McGowan DR, Schuster DM, Tsakok M, et al
    Bayesian penalised likelihood reconstruction (Q.Clear) of (18)F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation.
    Br J Radiol. 2018 Jan 5:20170727. doi: 10.1259/bjr.20170727.
    PubMed     Abstract available

  78. DENIS-BACELAR AM, Chittenden SJ, McCready VR, Divoli A, et al
    Bone lesion absorbed dose profiles in patients with metastatic prostate cancer treated with molecular radiotherapy.
    Br J Radiol. 2018 Jan 2:20170795. doi: 10.1259/bjr.20170795.
    PubMed     Abstract available

    December 2017
  79. BOUSTANI AM, Pucar D, Saperstein L
    Molecular imaging of prostate cancer.
    Br J Radiol. 2017 Dec 15:20170736. doi: 10.1259/bjr.20170736.
    PubMed     Abstract available

    November 2017
  80. BRIZMOHUN APPAYYA M, Sidhu HS, Dikaios N, Johnston EW, et al
    Characterizing indeterminate (Likert-scored 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multi-parametric MRI.
    Br J Radiol. 2017 Nov 30:20170645. doi: 10.1259/bjr.20170645.
    PubMed     Abstract available

  81. TOMITA N, Soga N, Ogura Y, Furusawa J, et al
    Effects of dose-escalated radiotherapy in combination with long-term androgen deprivation on prostate cancer.
    Br J Radiol. 2017 Nov 22:20170431. doi: 10.1259/bjr.20170431.
    PubMed     Abstract available

  82. TANAKA O, Komeda H, Tamaki M, Seike K, et al
    Comparison of MRI visualisation between linearly placed iron-containing and non-iron-containing fiducial markers for prostate radiotherapy.
    Br J Radiol. 2017 Nov 9:20170612. doi: 10.1259/bjr.20170612.
    PubMed     Abstract available

  83. PIZARRO F, Hernandez A
    Optimization of radiotherapy fractionation schedules based on radiobiological functions.
    Br J Radiol. 2017;90:20170400.
    PubMed     Abstract available

  84. CIARDO D, Jereczek-Fossa BA, Petralia G, Timon G, et al
    Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments.
    Br J Radiol. 2017;90:20170021.
    PubMed     Abstract available

    August 2017
  85. KWON MR, Kim CK, Kim JH
    PI-RADS version 2: Evaluation of diffusion-weighted imaging interpretation between B = 1000 and B = 1500 s/mm2.
    Br J Radiol. 2017 Aug 22:20170438. doi: 10.1259/bjr.20170438.
    PubMed     Abstract available

    July 2017
  86. SAMLALI H, Udrescu C, Lapierre A, Enachescu C, et al
    Prospective evaluation of a specific technique of sexual function preservation in external beam radiotherapy for prostate cancer.
    Br J Radiol. 2017 Jul 27:20160877. doi: 10.1259/bjr.20160877.
    PubMed     Abstract available

  87. HAUTH E, Halbritter D, Jaeger H, Hohmuth H, et al
    Diagnostic value of semiquantitative and quantitative analysis of functional parameters in multiparametric MRI of the prostate.
    Br J Radiol. 2017 Jul 27:20170067. doi: 10.1259/bjr.20170067.
    PubMed     Abstract available

  88. GERLACH S, Kuhlemann I, Ernst F, Furweger C, et al
    Impact of robotic ultrasound image guidance on plan quality in SBRT of the prostate.
    Br J Radiol. 2017 Jul 27:20160926. doi: 10.1259/bjr.20160926.
    PubMed     Abstract available

    June 2017
  89. FLUX GD
    Imaging and dosimetry for radium-223: the potential for personalized treatment.
    Br J Radiol. 2017 Jun 27:20160748. doi: 10.1259/bjr.20160748.
    PubMed     Abstract available

    May 2017
  90. GASNIER A, Parvizi N
    Updates on the diagnosis and treatment of prostate cancer.
    Br J Radiol. 2017 May 30:20170180. doi: 10.1259/bjr.20170180.
    PubMed     Abstract available

  91. ROBINSON JL, Tzou KS, Parker AS, Heckman MG, et al
    GATA2 expression and biochemical recurrence following salvage radiation therapy for relapsing prostate cancer.
    Br J Radiol. 2017 May 9:20170174. doi: 10.1259/bjr.20170174.
    PubMed     Abstract available

    January 2017
  92. HARVEY H, Orton MR, Morgan VA, Parker C, et al
    Volumetry of the Dominant Intraprostatic Tumour Lesion: Intersequence and Interobserver Differences on Multiparametric MRI.
    Br J Radiol. 2017 Jan 5:20160416. doi: 10.1259/bjr.20160416.
    PubMed     Abstract available

    December 2016
  93. CHAN J, Carver A, Brunt JN, Vinjamuri S, et al
    Effect of androgen deprivation therapy on intra-prostatic tumour volume identified on 18F choline PET/CT for prostate dose painting radiotherapy.
    Br J Radiol. 2016 Dec 20:20160818.
    PubMed     Abstract available

    November 2016
  94. LJUNGBERG M, Pretorius PH
    SPECT/CT: an update on technological developments and clinical applications.
    Br J Radiol. 2016 Nov 15:20160402.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.